[/QUOTE]
Yes, you're right. Until a drug is FDA approved it cannot be marketed in the US. Orphan Drug and Breakthrough status are simply (at this stage) simply indicative of the more facilitated processes a drug still needs to go trough to get the required efficacy evidence to gain approval.
FDA Grants Orphan Drug Designation, page-18
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.82 |
Change
-0.150(0.75%) |
Mkt cap ! $2.523B | |||
| Open | High | Low | Value | Volume |
| $19.96 | $19.96 | $19.69 | $2.839M | 143.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 868 | $19.82 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.83 | 298 | 9 |
View Market Depth
| Last trade - 15.11pm 05/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |